Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CTI (Computerized Thermal Imaging) hits back at FDA over breast imaging PMA (Pre-market Approval) decision

This article was originally published in Clinica

Executive Summary

Computerized Thermal Imaging (CTI) is trying unusually aggressive tactics after failing to win FDA approval for its thermal breast imaging device. The company filed a citizen petition with the agency late last month, demanding that the agency correct the administrative record on its premarket approval application, claiming that "pervasive bias" by the review staff "severely and improperly prejudiced" the submission.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel